American Society For Dermatologic Surgery Supports Current Labeling Of Allergan's Botox(R) Products (Medical News Today)
The American Society for Dermatologic Surgery (ASDS), a 5,000 member specialty organization of leaders in the field of cosmetic and medically necessary skin surgery, is aware of the petition filed by Public Citizen with the U.S. Food and Drug Administration (FDA) regarding Allergan's Botox products.

Merck Receives Not Approvable Letter From FDA For OTC MEVACOR (lovastatin) 20 Mg (Medical News Today)
Merck & Co., Inc. received a not approvable letter from the U.S Food and Drug Administration (FDA) to its New Drug Application (NDA) seeking approval for over-the-counter (OTC) MEVACOR (lovastatin) 20 mg. MEVACOR OTC had been under review by the FDA since 1999; Advisory Committee reviews in 2000 and 2005 resulted in not approvable actions.